Abstract

The altered expression of cell surface chondroitin sulfate (CS) and dermatan sulfate (DS) in cancer cells has been demonstrated to play a key role in malignant transformation and tumor metastasis. However, the functional highly sulfated structures in CS/DS chains and their involvement in the process have not been well documented. In the present study, a structural analysis of CS/DS from two mouse Lewis lung carcinoma (3LL)-derived cell lines with different metastatic potentials revealed a higher proportion of Delta(4,5)HexUA-GalNAc(4,6-O-disulfate) generated from E-units (GlcUA-GalNAc(4, 6-O-disulfate)) in highly metastatic LM66-H11 cells than in low metastatic P29 cells, although much less CS/DS is expressed by LM66-H11 than P29 cells. This key finding prompted us to study the role of CS-E-like structures in experimental lung metastasis. The metastasis of LM66-H11 cells to lungs was effectively inhibited by enzymatic removal of tumor cell surface CS or by preadministration of CS-E rich in E-units in a dose-dependent manner. In addition, immunocytochemical analysis showed that LM66-H11 rather than P29 cells expressed more strongly the CS-E epitope, which was specifically recognized by the phage display antibody GD3G7. More importantly, this antibody and a CS-E decasaccharide fraction, the minimal structure recognized by GD3G7, strongly inhibited the metastasis of LM66-H11 cells probably by modifying the proliferative and invading behavior of the metastatic tumor cells. These results suggest that the E-unit-containing epitopes are involved in the metastatic process and a potential target for the diagnosis and treatment of malignant tumors.

Highlights

  • The poor prognosis of cancer is mainly due to the metastasis of malignant cells from the primary neoplasm

  • Comparison of Amount and Composition of chondroitin sulfate (CS)/dermatan sulfate (DS) between P29 and LM66-H11 Cells—To investigate the possible alteration in the expression of CS/DS in the carcinoma clones with different metastatic potentials, GAGs were extracted from P29 and LM66-H11 cells, as described under “Experimental Procedures,” and the amount and composition of CS/DS in both GAG preparations were determined by digestion with CSase ABC followed by anion exchange HPLC

  • The results showed that the deca- and dodecasaccharides were substantial inhibitors of the metastasis of LM66-H11 cells compared with the hexa- and octasaccharides (Fig. 6), suggesting that E-unit-containing decasaccharides recognized by the antibody GD3G7 act as minimal sized functional domains of CS/DS chains in the metastatic process

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—CSase ABC (EC 4.2.2.4), highly purified CSase ABC (protease-free CSase ABC), standard unsaturated disaccharides, CS-A from whale cartilage, CS-B from porcine skin, CS-C and CS-D from shark cartilage, and CS-E from squid cartilage were purchased from Seikagaku Corp. (Tokyo, Japan). The dried acetone powder was digested with heat-activated (60 °C, 30 min) actinase E in 200 ␮l of 0.1 M sodium borate, pH 8.0, containing 10 mM calcium acetate at 60 °C for 48 h. Disaccharide Composition Analysis of CS Chains—The disaccharide composition of the GAG preparations from both Lewis lung carcinoma cell lines was determined as previously described [32]. The 2AB-labeled digest was analyzed by anion exchange HPLC on a PA-03 silica column (YMC-Pack PA, Kyoto, Japan). Disaccharide composition of CS/DS chains in Lewis lung carcinoma (3LL)-derived low metastatic P29 and high-metastatic LM66-H11 cells. The GAG preparation from each carcinoma cell line was digested with chondroitinase ABC and analyzed by anion exchange HPLC after labeling with a fluorophore 2AB as detailed under “Experimental Procedures.”

Molar ratio of disaccharide
Sequence bp
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call